Distant Metastasis After Chemoradiation and Image Guided Adaptive Brachytherapy in Locally Advanced Cervical Cancer

DM is a substantial burden in patients with locally advanced cervical cancer, with the lungs, distant lymph nodes, and bones being the most frequent sites. Risk factors such as nonsquamous histology, nodal involvement, and large target volumes at brachytherapy are critical considerations for identifying high-risk patients in future studies. These findings highlight the need for tailored strategies to mitigate DM in this patient population.

Authors

Institutions

Publication Details

Journal
International Journal of Radiation Oncology*Biology*Physics
Published
2025-05-10
DOI
https://doi.org/10.1016/j.ijrobp.2025.04.037
Citations
4
Primary Topic
Endometrial and Cervical Cancer Treatments
Type
article
Field-Weighted Citation Impact
8.23

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Distant Metastasis After Chemoradiation and Image Guided Adaptive Brachytherapy in Locally Advanced Cervical Cancer

Bhavana Rai, Rachel Cooper, Bradley R. Pieters, Umesh Mahantshetty et al.
4 citations
International Journal of Radiation Oncology*Biology*Physics
Endometrial and Cervical Cancer Treatments
8.23
article

Distant Metastasis After Chemoradiation and Image Guided Adaptive Brachytherapy in Locally Advanced Cervical Cancer

Bhavana Rai, Rachel Cooper, Bradley R. Pieters, Umesh Mahantshetty, Peter Hoskin, Remi A. Nout, Robin Ristl, Nicole Eder-Nesvacil, Fleur Huang, Johannes Knoth, Astrid A.C. de Leeuw, Ina M. Jürgenliemk‐Schulz, Jacob Christian Lindegaard, Kjersti Bruheim, Maximilian Schmid, Lars Fokdal, Barbara Šegedin, Rohini Hawaldar, Alina Sturdza, Christine Haie-Méder, Marie A.D. Haverkort, Kari Tanderup, Christian Kirisits, Richard Pötter, Li Tee Tan, Daniela Boryshchuk, Sadhana Kannan, Erik Van Limbergen, Israël Fortin
article en
4 citations

Abstract

DM is a substantial burden in patients with locally advanced cervical cancer, with the lungs, distant lymph nodes, and bones being the most frequent sites. Risk factors such as nonsquamous histology, nodal involvement, and large target volumes at brachytherapy are critical considerations for identifying high-risk patients in future studies. These findings highlight the need for tailored strategies to mitigate DM in this patient population.

International Journal of Radiation Oncology*Biology*PhysicsVol. 123(2)
Oslo University Hospital (NO), University of Ljubljana (SI), University of Alberta (CA), Homi Bhabha National Institute (IN), Tata Memorial Hospital (IN), Universitair Ziekenhuis Leuven (BE), Mount Vernon Hospital (GB), St James's University Hospital (GB), Institut Gustave Roussy (FR), Aarhus University Hospital (DK), Hôpital Maisonneuve-Rosemont (CA), University Medical Center Utrecht (NL), Institute of Oncology Ljubljana (SI), Comprehensive Cancer Center Vienna (AT), Mount Vernon Cancer Centre (GB), Radiotherapiegroep (NL), Erasmus MC Cancer Institute (NL), Addenbrooke's Hospital (GB), Mount Vernon Hospital (GB), Post Graduate Institute of Medical Education and Research (IN), Medical University of Vienna (AT), KU Leuven (BE)
Varian Medical Systems, Kræftens Bekæmpelse, Elekta, Austrian Science Fund, Universität Wien, Medizinische Universität Wien, Dansk Kræftforsknings Fond
Openalex Percentile: Top 3%
Endometrial and Cervical Cancer Treatments
8.23
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.